PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
35079117-6	2022	Multianalyte biomarkers based on TCS estimates predicted response to anti-PD-1 therapy in three different cancers and outperformed the indicated PD-L1 test, as well as Tumor Mutational Burden.	9-ethyl-N-(3,4,5-trimethoxyphenyl)carbazole-3-sulfonamide	33-36	programmed cell death 1	Homo sapiens	74-78	
29467945-11	2018	High PD-L1 positivity in TCs, especially in SqCCs, indicated that PD-1/PD-L1 targeted therapy may be a promising therapeutic approach.	9-ethyl-N-(3,4,5-trimethoxyphenyl)carbazole-3-sulfonamide	25-28	programmed cell death 1	Homo sapiens	66-70